Wellgistics Health Inc (WGRX)
NASDAQHealth CareMedical - DistributionSnapshot 2026-09-04
$3.59+15.06%
Close 2026-07-28 · 1-day change
NASDAQHealth CareMedical - DistributionSnapshot 2026-09-04
Research Workspace
Put WGRX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar under pressure — Company resolves Nasdaq delisting notice: Nasdaq delisting notice active (stockholders' equity non-compliant) vs target: listing maintained beyond Q3 2026.
View ThesisManagement screens weak on capital allocation, margins, market reaction to earnings.
View ManagementThis stock is highly volatile — it swings about 5% on a typical day and fell roughly 97% in its worst 12-month stretch.
View RiskWGRX's growth depends on improving financial performance and sector trends. The company recently climbed back into the top half of its industry. Revenue growth is steady, but the company remains unprofitable. WGRX trades at a low multiple compared to its peers. This suggests the market may not fully value its potential. The primary risk is the Nasdaq delisting notice due to equity non-compliance. Our read remains provisional.
Trailing returns as of 2026-07-28. WGRX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare WGRX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| WGRX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Health Care (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put WGRX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Reverse split may affect Nasdaq compliance.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-28. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Acquisition aligns with growth objectives.